Article Detail - JE Part B
Billing and Coding: MolDX: Myriad’s BRACAnalysis CDx (A55294) - R9 - Effective July 28, 2022
This coverage article has been revised and published for notice under contract numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).
Effective Date: July 28, 2022
Summary of Article Changes:
Under Article Title revised to Germline testing for use of PARP inhibitors.
Under Article Text deleted second paragraph and revised the verbiage in the third paragraph. Added new verbiage following the third paragraph. Deleted Table 1, fourth, fifth, and sixth paragraphs. Revised seventh paragraph first sentence to read, “To report service, please submit the following claim information”. Revised the seventh paragraph first bullet to read, “Select appropriate CPT® code”. Deleted the eighth and nineth paragraphs.
Under CPT/HCPCS Codes Group 1: Codes added 81479.
Visit the Molecular Diagnostic Services (MolDX) webpage to access the MolDX Medicare Coverage Article from the “Covered Tests” or the “Excluded Tests” webpage.
To view the complete listing of coverage articles and/or access the Active, Future, or Retired articles available in the CMS MCD, visit the Medicare Coverage Articles webpage.
Last Updated Wed, 03 Aug 2022 15:55:03 +0000